Director, Supplier Quality, Inspection & Audit (contractor)

*Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company,* *is a clinical-stage company developing orexin receptor 2 (OX2R) agonists as a new class of medicines for the treatment of narcolepsy and potentially other sleep-wake disorders. Centessa’s lead investigational candidate – cleminorexton (formerly ORX750) – is being developed for narcolepsy type 1, narcolepsy type 2, and idiopathic hypersomnia. Centessa's OX2R agonist portfolio includes additional clinical and preclinical-stage assets with potential utility across a broader range of neurological, neurodegenerative, and neuropsychiatric conditions.*

*Headquartered in Boston, Massachusetts, Centessa was recognized as a* *Great Place to Work**® in 2026.*

Description of Role

The Director, Supplier Quality, Inspection & Audit (contractor) will provide strategic leadership and tactical support for supplier quality management, GxP supplier audit programs, inspection readiness, and supplier quality oversight across the portfolio. This contractor position reports to our Executive Director, GMP Quality Assurance as part of our Product Quality team.

Key Responsibilities

Supplier Quality Leadership

• Develop the strategy and tactically support the supplier quality program
• Manage and confirm robustness of the supplier qualification and monitoring programs
• Provide routine status updates/performance metrics on qualified suppliers
• Manage the installment and routine review of quality agreements Audit Program Management
• Lead GMP, GCP, GLP, CSA and GVP supplier audit programs.
• Develop annual audit plans and risk-based audit strategies.
• Perform audits as required
• Review audit findings and track CAPA to closure
• Develop and monitor implementation of remediation plans, as required.

Inspection Readiness

• Drive global inspection readiness initiatives.
• Collaborate to develop process and tools to facilitate inspection and audit management with